Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Oktober 2021 02:15 ET | Quelle: Curium

Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T

St. Louis, MO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Curium announced today that the Company has received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin its Phase 3...
09. Mai 2018 08:03 ET | Quelle: Exosome Diagnostics

Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test

Waltham, MA, May 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has continued to make significant progress in expanding contracts to provide laboratory services and ExoDx®...
19. September 2017 07:31 ET | Quelle: Exosome Diagnostics

Exosome Diagnostics and Chesapeake Urology Partner to Evaluate Clinical Value of ExoDx® Prostate(IntelliScore) in First Study Under Novel Evidence Development Collaboration

Baltimore, MD and Boston, MA, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics (ExoDx) and Chesapeake Urology announced today that they have initiated a new evidence development study to...